Teva Must Surrender Generics To Get Cephalon: FTC
The Federal Trade Commission announced Friday it will require Teva Pharmaceutical Industries Ltd. to sell the rights to a generic cancer pain drug and generic muscle relaxant as conditions of its...To view the full article, register now.
Already a subscriber? Click here to view full article